{
    "SPADE_N_15660": {
        "Sequence Information": {
            "Peptide Name": "M-myrmicitoxin(01)-Tb1a, Bicarinalin, P16",
            "Sequence": "KIKIPWGKVKDFLVGGMKAV",
            "Sequence Length": 20,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antiparasitic",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Tetramorium bicarinatum",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "W8GNV3",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/W8GNV3",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Identification and characterization of a novel antimicrobial peptide from the venom of the ant Tetramorium bicarinatum.",
                    "Pubmed ID": "22960382",
                    "Reference": "Peptides. 2012;38:363-370",
                    "Author": "Rifflet A, Gavalda S, Téné N, Orivel J, Leprince J, Guilhaudis L, Génin E, Vétillard A, Treilhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22960382"
                },
                {
                    "Title": "Biochemical and biophysical combined study of bicarinalin, an ant venom antimicrobial peptide.",
                    "Pubmed ID": "27058430",
                    "Reference": "Peptides. 2016;79:103-113",
                    "Author": "Téné N, Bonnafé E, Berger F, Rifflet A, Guilhaudis L, Ségalas-Milazzo I, Pipy B, Coste A, Leprince J, Treilhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27058430"
                },
                {
                    "Title": "Anti-Helicobacter pylori Properties of the Ant-Venom Peptide Bicarinalin.",
                    "Pubmed ID": "29286296",
                    "Reference": "Toxins (Basel). 2017;10:E21",
                    "Author": "Guzman J, Téné N, Touchard A, Castillo D, Belkhelfa H, Haddioui-Hbabi L, Treilhou M",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29286296"
                }
            ],
            "Mass": 2214.76,
            "PI": 10.18,
            "Net Charge": 4,
            "Hydrophobicity": 0.26,
            "Frequent Amino Acids": "KGV",
            "Absent Amino Acids": "CEHNOQRSTUY",
            "Basic Residues": 5,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 9,
            "Polar Residues": 11,
            "Positive Residues": 5,
            "Negative Residues": 1,
            "SPADE ID": "SPADE_N_15660",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13866",
                    "Similarity": 1.0,
                    "Sequence": "KIKIPWGKVKDFLVGGMKAVGKK"
                },
                {
                    "SPADE_ID": "SPADE_N_15661",
                    "Similarity": 1.0,
                    "Sequence": "KIKIPWGKVKDFLVGGMKAV"
                },
                {
                    "SPADE_ID": "SPADE_UN_06662",
                    "Similarity": 1.0,
                    "Sequence": "MAATRKFIYVLSHFLFLFLVTKITDARVCKSDKDCKDIIIYRYILKCRNGECVKIKI"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=180 µg/ml,Human erythrocytes:50% Hemolysis=720 µg/ml",
            "Target Organism": "Staphylococcus aureus(MIC=6.3µg/ml),Staphylococcus aureus CIP 53.156(MIC=6.4µg/ml),Staphylococcus xylosus(MIC=1.3µg/ml),Staphylococcus xylosus ATCC 35033(MIC=1µg/ml),Escherichia coli CIP 76.24(MIC=24.4µM),Cronobacter sakazakii ATCC 29544(MIC=5.80µM),Pseudomonas aeruginosa CIP 82118(MIC=12.2µM),Pseudomonas aeruginosa ATCC 15442(MIC=8.7µM),Salmonella enterica ATCC 29934(MIC=5.4µM),Enterococcus hirae CIP 5855(MIC=12.2µM),Staphylococcus aureus ATCC 43300(MIC=8.7µM),Bacillus subtilis CIP 5262(MIC=24.4µM),Aspergillus niger CIP 143183(MIC=0.75µM),Candida albicans CIP 48.72(MIC=17.3µM),Candida albicans CAAL 117(MIC=17.3µM),Geotrichum candidum ATCC 204307(MIC=97.5µM),Saccharomyces cerevisiae(MIC=6.1µM),Leishmania infantum MHOM/MA/67/ITMAP-263(MIC=1.5µM),Escherichia coli CIP 76.24(MBC=24.4µM),Cronobacter sakazakii ATCC 29544(MBC=6.1µM),Pseudomonas aeruginosa CIP 82118(MBC=24.4µM),Pseudomonas aeruginosa ATCC 15442(MBC=12.2µM),Salmonella enterica ATCC 29934(MBC=6.1µM),Enterococcus hirae CIP 5855(MBC=12.2µM),Staphylococcus aureus ATCC 43300(MBC=12.2µM),Bacillus subtilis CIP 5262(MBC=24.4µM),Aspergillus niger CIP 143183(MBC=0.76µM),Candida albicans CIP 48.72(MBC=24.4µM),Candida albicans CAAL 117(MBC=24.4µM),Geotrichum candidum ATCC 204307(MBC=97.5µM),Saccharomyces cerevisiae(MBC=6.1µM),Helicobacter pylori ATCC 43504(MIC50=8.6µg/ml),Helicobacter pylori(MIC50=2.2µg/ml),Human gastric carcinoma NCI-N87(50-60% Cytotoxicity=1.7µM),Murine macrophage cells RAW 264.7(50-60% Cytotoxicity=39.2µM)"
        }
    }
}